As demonstrated in this study, in which CD33+ AML cell lines lacking detectable expression of CD80 or CD86 were efficiently killed by AMG 330, in vitro cytotoxicity induced by BiTE antibody constructs is indeed independent of CD80 or CD86-induced T-cell activation. This evidence concerns the gene CD86 and acute myeloid leukemia.